Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Thoracic 6Gastrointestinal 6CNS 6Myeloid 5Genitourinary 4Tumor-Agnostic 3Gynecologic 3Breast 3Other hematologic neoplasm 2Lymphoid 2Head & Neck 2Sarcoma 1NET 1Endocrine 1Dermatologic 1

Conditions

Lymphoma 2Hodgkin Disease 1Brain Neoplasms 1

Interventions

Rituximab 1401Cyclophosphamide 1305Vincristine 668Doxorubicin 587Etoposide 527Prednisone 510Cytarabine 486fludarabine 469Methotrexate 445Dexamethasone 413fludarabine phosphate 400Lenalidomide 356Filgrastim 343Bendamustine Hydrochloride 282Radiotherapy 267venetoclax 260ibrutinib 258obinutuzumab 235Peripheral Blood Stem Cell Transplantation 234Melphalan 230Granulocyte Colony-Stimulating Factor 215Bortezomib 204Gemcitabine 202Busulfan 188Whole-Body Irradiation 187Mycophenolic Acid 175Tacrolimus 165Specimen Handling 162Magnetic Resonance Spectroscopy 155Calcium Dobesilate 150

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phlebotomy × Lymphoid × Clear all
NCT01078350 2017-11-20

Consent for Obtaining Additional Tissue at the Time of a Diagnostic Biopsy

Stanford University

Completed
93 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

NCT01540175 2015-07-14

IROPAST

St. Jude Children's Research Hospital

Completed
31 enrolled
CNSLymphoid

Brain Neoplasms, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡